IJMPS - 15(1), January, 2025
Pages: 01-07
Computational Chemistry oriented Research of Novel Indole Compounds
Author: Shubham Anant, Arin Bhattacharya
Category: Pharmaceutical Sciences
[Download PDF]
Abstract:
Background: Indole derivatives have attracted considerable interest in medicinal chemistry due to their diverse biological activities. Despite their potential, challenges persist in optimizing these molecules for efficacy, selectivity, and safety. Computational chemistry offers a powerful toolkit to address these limitations in early-stage drug discovery.
Objectives: This research investigates the design, optimization, and mechanistic profiling of novel indole-based compounds using a suite of in silico techniques. The goal is to identify potent and selective drug-like candidates with enhanced pharmacological profiles suitable for targeting various disease-associated biomolecules.
Methods: A range of computational techniques was employed to assess indole-based derivatives. Pharmacokinetics [ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiling], bioavailability, and drug-likeliness studies were performed using SwissADME online tool. In silico target identification tools were utilized to predict off-target interactions.
Results: The evaluation of novel indole-based derivatives through comprehensive in silico techniques revealed several promising candidates with favorable pharmacokinetic and safety profiles. SwissADME analysis indicated high oral bioavailability, good gastrointestinal absorption, and optimal drug-likeness scores for the top-performing compounds. ADMET profiling confirmed acceptable absorption, distribution, and metabolic stability, while predicting minimal toxicity risks.
Conclusions: This study underscores the effectiveness of integrated computational approaches in evaluating the pharmacological and toxicological potential of indole-based derivatives. The use of SwissADME and other in silico tools facilitated a detailed assessment of ADMET properties, bioavailability, and drug-likeness leading to the identification of safe and potent lead compounds. These findings establish a strong foundation for experimental validation and development of indole derivatives as therapeutic agents across multiple disease domains.
Keywords: Indole derivatives, ADMET profiling, Drug-likeness, In silico, Target prediction, Bioavailability
Citation:
Shubham Anant, Arin Bhattacharya. Computational Chemistry oriented Research of Novel Indole Compounds . Int J Med Phar Sci. 2025 15(1), January, 01-07
References:
1. Sharma RK, Mehta A, Roy DS. Computational insights into indole-based kinase inhibitors. J Mol Drug Des. 2022;17(3):201– 213.
2. Zhang Y, Kaur R, Patel MJ. Novel approaches in designing bioactive indoles: A review. Med Chem Lett. 2021;12(2):88– 102.
3. Williams TD, Singh N, Ahmed Z. In silico evaluation of indole analogues targeting PI3K. Int J Comp Chem. 2020;19(5):345– 358.
4. Fernandes L, Cho E, Anand S. QSAR modeling of substituted indoles with anti-cancer potential. J Pharm Innov. 2019;24(1):15–29.
5. Das S, Oliveira C, Tripathi N. A DFT study on the electronic behavior of halogenated indoles. Comput Chem Bull.
2023;11(4):223–235.
6. Khan J, Liu Y, Novak K. Docking-based identification of novel indole scaffolds as HDAC inhibitors. Curr Drug Targets. 2018;16(9):711–725.
7. Goswami R, Lee H, Behera M. ADMET prediction and optimization of indole-derived leads. Chem Bio Interact.
2021;23(6):389–401.
8. Naik R, Zhu J, Sharma D. Molecular dynamics simulations of indole-DNA interactions. J Biol Struct Dyn. 2022;6(2):87–101.
9. Bose B, Fernandez A, Yadav N. Machine learning in indole drug design: a data-driven review. Artif Intell Drug Discov. 2024;4(1):12–27.
10. Park S, Patel H, Menon R. Virtual screening of indole-based ligands against COX-2. J Mol Model. 2019;10(3):155–169.
11. Rao K, Alam M, Singh V. Pharmacophore modeling of novel indole derivatives targeting EGFR. Biochem Pharmacol Res. 2015;13(7):501–515.
12. Kapoor N, Tan W, Gupta PK. Design and optimization of antiinflammatory indoles. Asian J Comp Pharm. 2020;9(5):275– 290.
13. Lima R, Banerjee A, Sheikh A. Docking and 3D-QSAR analysis of indole antifungal agents. J Med Comput Mol Simul. 2021;14(8):105–120.
14. Verma T, Jung M, Li Q. Hybrid indoles: in silico screening for antitubercular activity. Trop Med Chem. 2018;6(4):333–346.
15. Chen X, Mitra P, Shukla R. A computational perspective on indole derivatives in neurodegenerative diseases. Neurother Anal. 2022;3(2):45–61.
|